ALB and neoplasm: Hence, endogenous HSA can serve as a valuable carrier for targeted drug delivery to tumors by utilizing albumin-binding moieties, enabling the biomimetic delivery of drugs to tumor cells (Zhang et al., 2017; Rapozzi et al., 2022).